Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06141109
Status:
RECRUITING
Last Update Posted:
2023-11-21
First Post:
2023-11-09
Brief Title:
Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma
Sponsor:
Xian Xintong Pharmaceutical Research CoLtd
Organization:
Xian Xintong Pharmaceutical Research CoLtd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Safety Issues |
| Efficacy |
| MTD |
Keywords: